Avidinorubicin
Avidinorubicin is an antibiotic found in Streptomyces avidinii, exhibiting activity against both Gram-positive and Gram-negative bacteria. Additionally, Avidinorubicin inhibits thrombin -induced platelet aggregation, with an IC50 of 7.9 μM[1].
Product Specifications
CAS Number
135447-13-1
UNSPSC
12352005
Target
Antibiotic; Bacterial
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection; Cardiovascular Disease
Smiles
C[C@@H]1O[C@@H](O[C@@H]2[C@](N)(C[C@H](O[C@H]2C)O[C@@H]3[C@](N)(C[C@H](O[C@H]3C)O[C@@H]4[C@@]5(O[C@H]([C@H]([C@@H]4N(C)C)O)OC6=C7C(C(C(C(O)=C89)=C(C7=O)C(O)=C9C[C@@](O)(C[C@@H]8O[C@H]%10C[C@@H]([C@@H]([C@@H](O%10)C)O)N(C)C)C)=O)=CC=C56)C)C)C)C[C@@H]([C@@H]1OC(CCC(O)=O)=O)OC
Molecular Formula
C60H86N4O22
Molecular Weight
1215.34
References & Citations
[1]Aoki M, et al. Structural studies on avidinorubicin, a novel anthracycline with platelet aggregation inhibitory activity. J Antibiot (Tokyo) . 1991 Jun;44 (6) :635-45.|[2]Yang J, et al. Recent advances in chemical synthesis of amino sugars[J]. Molecules, 2023, 28 (12) : 4724.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740718-500 1x 500 µL
HER-2 / CD340 (HRB2/718), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details